402668

Veronique Riethuisen

Position
Vice President GI, Regenerative Medicine, Externalization R&D BD
Company
Takeda
Location
MA MA UNITED STATES
Message Notes
Networks
Bio

None provided.

Agenda
bio2018-mybio-sessionicon-extrafee1

Business Development Fundamentals Course - Day 1

7:00 AM–7:00 PM Jun 1, 2018

Room 206AB, Level 2

Anjan AralihalliChief Business Officer; Venture Partner atGLyPharma Therapeutic; CTI Life Sciences Fund II Mark CooperPrincipal atFaber Daeufer & Itrato PC Kathleen DenisCLP-Founding Director atOffice of Technology Transfer, The Rockefeller University Philippe NoreManaging Partner atPalo Alto BioVentures Veronique RiethuisenVice President GI, Regenerative Medicine, Externalization R&D BD atTakeda Pauline Jen RyanPartner atRed Sky Partners John SeligManaging Partner atWaveEdge Capital LLC Robert SilvermanSenior Vice President and General Counsel atCONCERT PHARMACEUTICALS Patricia SinatraManaging Director atVector Strategic Advisors Kate SkrableDirector of Alliance Management atGenentech Partnering Dr. Ken WeberPartner atKilpatrick Townsend
Add to myBIO Planner Notes
bio2018-mybio-sessionicon-extrafee1

Business Development Fundamentals Course - Day 2

7:30 AM–5:00 PM Jun 2, 2018

Room 206AB, Level 2

Anjan AralihalliChief Business Officer; Venture Partner atGLyPharma Therapeutic; CTI Life Sciences Fund II Mark CooperPrincipal atFaber Daeufer & Itrato PC Kathleen DenisCLP-Founding Director atOffice of Technology Transfer, The Rockefeller University Philippe NoreManaging Partner atPalo Alto BioVentures Veronique RiethuisenVice President GI, Regenerative Medicine, Externalization R&D BD atTakeda Pauline Jen RyanPartner atRed Sky Partners John SeligManaging Partner atWaveEdge Capital LLC Robert SilvermanSenior Vice President and General Counsel atCONCERT PHARMACEUTICALS Patricia SinatraManaging Director atVector Strategic Advisors Kate SkrableDirector of Alliance Management atGenentech Partnering Dr. Ken WeberPartner atKilpatrick Townsend
Add to myBIO Planner Notes
bio2018-mybio-sessionicon-extrafee1

Business Development Fundamentals Course - Day 3

7:30 AM–5:00 PM Jun 3, 2018

Room 206AB, Level 2

Anjan AralihalliChief Business Officer; Venture Partner atGLyPharma Therapeutic; CTI Life Sciences Fund II Mark CooperPrincipal atFaber Daeufer & Itrato PC Kathleen DenisCLP-Founding Director atOffice of Technology Transfer, The Rockefeller University Philippe NoreManaging Partner atPalo Alto BioVentures Veronique RiethuisenVice President GI, Regenerative Medicine, Externalization R&D BD atTakeda Pauline Jen RyanPartner atRed Sky Partners John SeligManaging Partner atWaveEdge Capital LLC Robert SilvermanSenior Vice President and General Counsel atCONCERT PHARMACEUTICALS Patricia SinatraManaging Director atVector Strategic Advisors Kate SkrableDirector of Alliance Management atGenentech Partnering Dr. Ken WeberPartner atKilpatrick Townsend
Add to myBIO Planner Notes
business_icon

Business Development & Finance

Achieving Success with the Build-to-Buy Model

1:00 PM–2:15 PM Jun 4, 2018

Room 252AB, Level 2

Dr. Abi BarrowInterim Executive Director atOffice of Technology Commercialization and Ventures at the University of Massachusetts Paul GraysonPresident & CEO atBird Rock Bio Dr. Alicia LeveyVice President of Business Development and Strategy atTempest Therapeutics Ms. Rama Padmanabhan, JDPartner atCooley Veronique RiethuisenVice President GI, Regenerative Medicine, Externalization R&D BD atTakeda Mr. Adam SimpsonPresident and CEO atPvP Biologics
Add to myBIO Planner Notes
Interests
None yet.